Catalyst Pharmaceuticals, Inc.
(NASDAQ : CPRX)

( )
CPRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
-0.28%35.9721.1%$138.29m
PRGOPerrigo Co. Plc
-1.88%74.076.7%$126.06m
SHPGShire PLC Sponsored ADR
0.46%171.430.4%$113.20m
ENDPEndo International Plc
-1.95%15.608.9%$89.97m
JAZZJazz Pharmaceuticals Plc
-0.16%173.972.2%$72.74m
ICPTIntercept Pharmaceuticals, Inc.
3.50%107.0018.7%$69.26m
SAGESAGE Therapeutics, Inc.
3.81%153.879.6%$58.93m
UTHRUnited Therapeutics Corporation
2.46%128.1114.4%$52.33m
CTLTCatalent Inc
0.70%41.582.6%$48.31m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.41%137.496.8%$42.64m
PTLAPortola Pharmaceuticals, Inc.
1.20%25.327.7%$42.29m
SUPNSupernus Pharmaceuticals, Inc.
-0.11%44.356.2%$40.49m
ICLRICON Plc
1.41%143.944.2%$39.20m
ZGNXZogenix, Inc.
0.86%46.9011.9%$38.19m
HZNPHorizon Pharma plc
-0.63%20.507.4%$33.41m

Company Profile

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.